Lensiprazine

CAS No. 327026-93-7

Lensiprazine( —— )

Catalog No. M34638 CAS No. 327026-93-7

Lensiprazine (SLV314) is a potent dopamine D(2) receptor antagonist that acts as a serotonin reuptake inhibitor , and can be used to study bipolar disorder and schizophrenia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 192 In Stock
10MG 274 In Stock
25MG 430 In Stock
50MG 600 In Stock
100MG 820 In Stock
200MG 1097 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lensiprazine
  • Note
    Research use only, not for human use.
  • Brief Description
    Lensiprazine (SLV314) is a potent dopamine D(2) receptor antagonist that acts as a serotonin reuptake inhibitor , and can be used to study bipolar disorder and schizophrenia.
  • Description
    Lensiprazine (SLV314) is a potent dopamine D(2) receptor antagonist that acts as a serotonin reuptake inhibitor , and can be used to study bipolar disorder and schizophrenia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine Receptor | 5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    327026-93-7
  • Formula Weight
    422.5
  • Molecular Formula
    C24H27FN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H]1OC2=C(C=CC=C2NC1=O)N3CCN(CCCC=4C=5C(NC4)=CC=C(F)C5)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sultopride hydrochlo...

    Sultopride Hydrochloride is a selective dopamine D2 and D3 receptor antagonist.

  • PNU-96391

    PNU-96391 is an antagonist of dopamine D2 and a partial agonist of 5-HT2A. PNU-96391 can be used in research on the treatment of chronic diseases.

  • PF-00217830

    PF-00217830 is a serotonin 1A receptor agonist, dopamine D2 receptor agonist, and serotonin 2A receptor antagonist.PF-00217830 may be used in the study of schizophrenia.